202 related articles for article (PubMed ID: 12464896)
41. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis.
Kolokotronis A; Doumas S
Clin Microbiol Infect; 2006 Mar; 12(3):202-11. PubMed ID: 16451405
[TBL] [Abstract][Full Text] [Related]
42. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
[TBL] [Abstract][Full Text] [Related]
43. Case report: symptomatic oral herpes simplex virus type 2 and asymptomatic genital shedding.
Olin L; Wald A
Herpes; 2006 May; 13(1):25-6. PubMed ID: 16733000
[TBL] [Abstract][Full Text] [Related]
44. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
Arduino PG; Porter SR
Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
[TBL] [Abstract][Full Text] [Related]
45. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma.
Vera-Llonch M; Oster G; Hagiwara M; Sonis S
Cancer; 2006 Jan; 106(2):329-36. PubMed ID: 16342066
[TBL] [Abstract][Full Text] [Related]
46. The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1.
Mador N; Panet A; Steiner I
J Neurovirol; 2002 Dec; 8 Suppl 2():97-102. PubMed ID: 12491159
[TBL] [Abstract][Full Text] [Related]
47. Quality-of-life measurement in patients undergoing radiation therapy for head and neck cancer: a Hong Kong experience.
Lo PS; Lo SK; Tong MC; Ku PK; Leung SF; van Hasselt CA
J Oncol Manag; 2004; 13(6):13-23. PubMed ID: 15648221
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology of orofacial herpes simplex virus infections in the general population in France: results of the HERPIMAX study.
Malvy D; Ezzedine K; Lançon F; Halioua B; Rezvani A; Bertrais S; Chanzy B; Malkin JE; Morand P; De Labareyre C; Hercberg S; El Hasnaoui A
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1398-403. PubMed ID: 17958848
[TBL] [Abstract][Full Text] [Related]
49. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
[TBL] [Abstract][Full Text] [Related]
50. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
51. Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection.
Cachay ER; Frost SD; Richman DD; Smith DM; Little SJ
J Infect Dis; 2007 May; 195(9):1270-7. PubMed ID: 17396995
[TBL] [Abstract][Full Text] [Related]
52. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
53. Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study.
Jham BC; França EC; Oliveira RR; Santos VR; Kowalski LP; da Silva Freire AR
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):355-8. PubMed ID: 17321446
[TBL] [Abstract][Full Text] [Related]
54. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
55. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy.
Kawaguchi K; Inamura H; Abe Y; Koshu H; Takashita E; Muraki Y; Matsuzaki Y; Nishimura H; Ishikawa H; Fukao A; Hongo S; Aoyagi M
Laryngoscope; 2007 Jan; 117(1):147-56. PubMed ID: 17202945
[TBL] [Abstract][Full Text] [Related]
56. Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients.
Robert PY; Adenis JP; Denis F; Alain S; Ranger-Rogez S
J Med Virol; 2003 Sep; 71(1):69-74. PubMed ID: 12858411
[TBL] [Abstract][Full Text] [Related]
57. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
Tyler KL
Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
[TBL] [Abstract][Full Text] [Related]
58. Unexpected high prevalence of herpes simplex virus (HSV) type 2 seropositivity and HSV genital shedding in pregnant women living in an East Paris suburban area.
LeGoff J; Saussereau E; Boulanger MC; Chemin C; Si-Mohamed A; Bélec L; Maisonneuve L
Int J STD AIDS; 2007 Sep; 18(9):593-5. PubMed ID: 17785000
[TBL] [Abstract][Full Text] [Related]
59. Period between completion of radiation therapy and prosthetic rehabilitation in edentulous patients: a retrospective study.
Gerngross PJ; Martin CD; Ball JD; Engelmeier RL; Gilbert HD; Powers JM; Narendran S; Chambers MS
J Prosthodont; 2005 Jun; 14(2):110-21. PubMed ID: 16011622
[TBL] [Abstract][Full Text] [Related]
60. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
Elting LS; Cooksley CD; Chambers MS; Garden AS
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
